Shi, C., Wang, Y., Tan, C., Zeng, X., Liu, Q. (2026). Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective. PLoS ONE. https://doi.org/10.1371/journal.pone.0348955